New PAH drug, macitentan, improves QoL in SERAPHIN

Following the trial's primary publication of clinical benefits from the drug, the new quality of life data are said to be “one of the most important considerations" in these patients, one investigator says.

Source: theHeart.org - September 13, 2013 Category: Cardiology Source Type: news